NOBIVAC® FELINE 1-HCPCh

A modified live vaccine for the immunisation of cats against feline panleukopaenia, rhinotracheitis, calici viruses and Chlamydia psittaci.

FOR ANIMAL USE ONLY           

NOBIVAC® FELINE 1-HCPCh

Reg. No. G3882 (Act 36/1947)

Namibia Reg. No. V04/24.2/908 [NS2]

This vaccine may only be used by or under the supervision of persons registered in terms of or authorised in terms of section 23 (1) (c) of the Veterinary and Para-Veterinary Professions Act, 1982 (Act No. 19 of 1982).

INDICATIONS

For use in cats only. A modified live vaccine for the immunisation of cats against panleukopenia, rhinotracheitis, calici viruses and Chlamydia psittaci.

COMPOSITION

Modified live vaccine containing feline panleukopenia, rhinotracheitis, calici viruses and Chlamydia psittaci.

STORAGE

  • Store between 2 °C and 8 °C.
  • Do not freeze.

WARNINGS

  • DO NOT VACCINATE PREGNANT CATS.
  • Vaccinate only healthy, non-parasitised cats.
  • In the case of accidental human exposure, contact your physician.
  • Dispose of any unused vaccine as well as all empty vaccine containers and vaccination equipment according to local waste disposal regulations.
  • KEEP OUT OF REACH OF CHILDREN, UNINFORMED PERSONS AND ANIMALS.
  • Although this vaccine has been extensively tested under a large variety of conditions, failure thereof may ensue as a result of a wide range of reasons. If this is suspected, seek veterinary advice and notify the registration holder.

PRECAUTIONS

  • Use new, non-chemically sterilised needles and syringes.
  • Do not mix Nobivac® Feline 1-HCPCh with other vaccines.
  • Wash and disinfect hands after vaccination.
  • In cats, fibrosarcoma may develop at the injection site.
  • Anaphylactic or hypersensitivity reactions may occur.

Antidote: Adrenaline, corticosteroids and antihistamines may all be indicated depending on the nature and severity of the reaction. 

DIRECTIONS FOR USE – USE ONLY AS DIRECTED

Shake until dissolved.

  • For vaccination of cats only.
  • Transfer the contents of the sterile diluent vial to the Nobivac® Feline 1-HCPCh vial aseptically.
  • Use entire contents immediately after rehydration.
  • Inject 1 dose (1 mℓ) of rehydrated vaccine subcutaneously or intramuscularly at 9 weeks of age or older and repeat with a second dose 3 to 4 weeks later.
  • Cats vaccinated for the first time at 12 weeks of age or older require 2 doses 3 to 4 weeks apart.
  • Annual revaccination with 1 dose is recommended.

PRESENTATION

25 x 1 dose (1 mℓ) vials with sterile diluent.

REGISTRATION HOLDER                               

Intervet South Africa (Pty) Ltd.                          

20 Spartan Road, Spartan                                

1619, RSA                                                         

Tel: +27 (0) 11 923 9300

Fax: +27 (0) 11 392 3158

www.msd-animal-health.co.za

DATE OF PUBLICATION OF THIS PACKAGE INSERT

06 December 2010